Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1977 Sep;39(9):935–938. doi: 10.1136/hrt.39.9.935

Relation between concentrations of digoxin in the myocardium and in the plasma.

A Malcolm, J Coltart
PMCID: PMC483350  PMID: 332215

Full text

PDF
935

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akera T., Larsen F. S., Brody T. M. Correlation of cardiac sodium- and potassium-activated adenosine triphosphatase activity with ouabain-induced inotropic stimulation. J Pharmacol Exp Ther. 1970 May;173(1):145–151. [PubMed] [Google Scholar]
  2. Besch H. R., Jr, Allen J. C., Glick G., Schwartz A. Correlation between the inotropic action of ouabain and its effects on subcellular enzyme systems from canine myocardium. J Pharmacol Exp Ther. 1970 Jan;171(1):1–12. [PubMed] [Google Scholar]
  3. Coltart D. J., Güllner H. G., Billingham M., Goldman R. H., Stinson E. B., Kalman S. M., Harrison D. C. Physiological distribution of digoxin in human heart. Br Med J. 1974 Dec 28;4(5947):733–736. doi: 10.1136/bmj.4.5947.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coltart J., Howard M., Chamberlain D. Myocardial and skeletal muscle concentrations of digoxin in patients on long-term therapy. Br Med J. 1972 May 6;2(5809):318–319. doi: 10.1136/bmj.2.5809.318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Doherty J. E. Digitalis glycosides. Pharmacokinetics and their clinical implications. Ann Intern Med. 1973 Aug;79(2):229–238. doi: 10.7326/0003-4819-79-2-229. [DOI] [PubMed] [Google Scholar]
  6. Doherty J. E., Perkins W. H., Flanigan W. J. The distribution and concentration of tritiated digoxin in human tissues. Ann Intern Med. 1967 Jan;66(1):116–124. doi: 10.7326/0003-4819-66-1-116. [DOI] [PubMed] [Google Scholar]
  7. Ewy G. A., Marcus F. I., Fillmore S. J., Matthews N. P. Digitalis intoxication--diagnosis, management and prevention. Cardiovasc Clin. 1974;6(2):153–174. [PubMed] [Google Scholar]
  8. Gillis R. A. Digitalis: A neuroexcitatory drug. Circulation. 1975 Nov;52(5):739–742. doi: 10.1161/01.cir.52.5.739. [DOI] [PubMed] [Google Scholar]
  9. Glantz S. A., Kernoff R., Goldman R. H. Age-related changes in ouabain pharmacology. Ouabain exhibits a different volume of distribution in adult and young dogs. Circ Res. 1976 Sep;39(3):407–414. doi: 10.1161/01.res.39.3.407. [DOI] [PubMed] [Google Scholar]
  10. Goldman R. H., Coltart D. J., Friedman J. P., Nola G. T., Berke D. K., Schweizer E., Harrison D. C. The inotropic effects of digoxin in hyperkalemia. Relation to (Na+,K+)-ATPase inhibition in the intact animal. Circulation. 1973 Oct;48(4):830–838. doi: 10.1161/01.cir.48.4.830. [DOI] [PubMed] [Google Scholar]
  11. Gorodischer R., Jusko W. J., Yaffe S. J. Tissue and erythrocyte distribution of digoxin in infants. Clin Pharmacol Ther. 1976 Mar;19(3):256–263. doi: 10.1002/cpt1976193256. [DOI] [PubMed] [Google Scholar]
  12. Güllner H. G., Stinson E. B., Harrison D. C., Kalman S. M. Correlation of serum concentrations with heart concentrations of digoxin in human subjects. Circulation. 1974 Oct;50(4):653–655. doi: 10.1161/01.cir.50.4.653. [DOI] [PubMed] [Google Scholar]
  13. Härtel G., Kyllönen K., Merikallio E., Ojala K., Manninen V., Reissell P. Human serum and myocardium digoxin. Clin Pharmacol Ther. 1976 Feb;19(2):153–157. doi: 10.1002/cpt1976192153. [DOI] [PubMed] [Google Scholar]
  14. Kim P. W., Krasula R. W., Soyka L. F., Hastreiter A. R. Postmortem tissue digoxin concentrations in infants and children. Circulation. 1975 Dec;52(6):1128–1131. doi: 10.1161/01.cir.52.6.1128. [DOI] [PubMed] [Google Scholar]
  15. Koch-Weser J. Drug therapy. Serum drug concentrations as therapeutic guides. N Engl J Med. 1972 Aug 3;287(5):227–231. doi: 10.1056/NEJM197208032870505. [DOI] [PubMed] [Google Scholar]
  16. Lukas D. S., De Martino A. G. Binding of digitoxin and some related cardenolides to human plasma proteins. J Clin Invest. 1969 Jun;48(6):1041–1053. doi: 10.1172/JCI106060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McRitchie R. J., Vatner S. F. The role of arterial baroreceptors in mediating the cardiovascular response to a cardiac glycoside in conscious dogs. Circ Res. 1976 Apr;38(4):321–326. doi: 10.1161/01.res.38.4.321. [DOI] [PubMed] [Google Scholar]
  18. Rosen M. R., Hordof A. J., Hodess A. B., Verosky M., Vulliemoz Y. Ouabain-induced changes in electrophysiologic properties of neonatal, young and adult canine cardiac Purkinje Fibers. J Pharmacol Exp Ther. 1975 Jul;194(1):255–263. [PubMed] [Google Scholar]
  19. Schwartz A. Is the cell membrane Na+, K+ -ATPase enzyme system the pharmacological receptor for digitalis? Circ Res. 1976 Jul;39(1):1–7. doi: 10.1161/01.res.39.1.1. [DOI] [PubMed] [Google Scholar]
  20. Sheiner L. B. The use of serum concentrations of digitalis for quantitative therapeutic decisions. Cardiovasc Clin. 1974;6(2):141–151. [PubMed] [Google Scholar]
  21. Smith T. W. Digitalis glycosides. 2. N Engl J Med. 1973 May 3;288(18):942–946. doi: 10.1056/NEJM197305032881805. [DOI] [PubMed] [Google Scholar]
  22. Smith T. W., Haber E. Digitalis (third of four parts). N Engl J Med. 1973 Nov 15;289(20):1063–1072. doi: 10.1056/NEJM197311152892005. [DOI] [PubMed] [Google Scholar]
  23. Steiness E. Renal tubular secretion of digoxin. Circulation. 1974 Jul;50(1):103–107. doi: 10.1161/01.cir.50.1.103. [DOI] [PubMed] [Google Scholar]
  24. Vere D. W. The significance of blood levels of drugs. Sci Basis Med Annu Rev. 1972:363–384. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES